Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Berrout, L."'
Autor:
Berrout, J., Kyriakopoulou, E., Moparthi, L., Hogea, A.S., Berrout, L., Ivan, C., Lorger, M., Boyle, J., Peers, C., Muench, S., Elies, Jacobo, Hu, X., Hurst, C., Hall, T., Umamaheswaran, S., Wesley, L., Gagea, M., Shires, M., Manfield, I., Knowles, M.A., Davies, S., Suhling, K., Gonzalez, Y.T., Carragher, N., Macleod, K., Abbott, N.J., Calin, G.A., Gamper, N., Zygmunt, P.M., Timsah, Z.
Yes
Recent evidence suggests that the ion channel TRPA1 is implicated in lung adenocarcinoma (LUAD) where its role and mechanism of action remain unknown. We have previously established that the membrane receptor FGFR2 drives LUAD progression th
Recent evidence suggests that the ion channel TRPA1 is implicated in lung adenocarcinoma (LUAD) where its role and mechanism of action remain unknown. We have previously established that the membrane receptor FGFR2 drives LUAD progression th
Externí odkaz:
http://hdl.handle.net/10454/12962
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Berrout J; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK., Kyriakopoulou E; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK., Moparthi L; Division of Clinical Chemistry and Pharmacology, Lund University, 221 85, Lund, Sweden., Hogea AS; School of Biomedical Sciences, University of Leeds, Leeds, LS2 9JT, UK., Berrout L; The University of Texas at Brownsville, Brownsville, TX, 78520, USA., Ivan C; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Lorger M; Leeds Institute of Cancer and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, LS9 7TF, Leeds, UK., Boyle J; Faculty of Medicine and Health, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, LS2 9JT, UK., Peers C; Faculty of Medicine and Health, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, LS2 9JT, UK., Muench S; School of Biomedical Sciences, University of Leeds, Leeds, LS2 9JT, UK., Gomez JE; Faculty of Medicine and Health, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, LS2 9JT, UK., Hu X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Hurst C; Faculty of Medicine and Health, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS2 9JT, UK., Hall T; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK., Umamaheswaran S; Centre for Biotechnology, Anna University, Chennai, Tamil Nadu, 600025, India., Wesley L; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK., Gagea M; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Unit 63, Houston, TX, 77054, USA., Shires M; Section of Pathology and Tumor Biology, Leeds Institute of Cancer and Pathology, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, UK., Manfield I; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK., Knowles MA; Faculty of Medicine and Health, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS2 9JT, UK., Davies S; School of Biomedical Sciences, University of Leeds, Leeds, LS2 9JT, UK., Suhling K; Department of Physics, King's College London, Strand, London, WC2R 2LS, UK., Gonzalez YT; Department of Physics, King's College London, Strand, London, WC2R 2LS, UK., Carragher N; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XR, UK., Macleod K; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XR, UK., Abbott NJ; Institute of Pharmaceutical Science, Franklin-Wilkins Building, King's College London, London, SE1 9NH, UK., Calin GA; Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Gamper N; School of Biomedical Sciences, University of Leeds, Leeds, LS2 9JT, UK., Zygmunt PM; Division of Clinical Chemistry and Pharmacology, Lund University, 221 85, Lund, Sweden., Timsah Z; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK. Z.Timsah@leeds.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2017 Oct 16; Vol. 8 (1), pp. 947. Date of Electronic Publication: 2017 Oct 16.